Average grip strength in men, by age

Men’s grip strength generally rises through early adulthood, stays relatively steady into midlife, then declines with age. In a large British reference study, median grip strength peaked at about 51 kg between ages 29 and 39. A low reading can be a useful reason to look more closely at muscle function, but it is not a diagnosis, a hormone test, or a forecast of how quickly you will age. The measurement method and the reference population matter.

Why grip strength matters for men

Grip strength is more than a measure of how hard you can squeeze. It is a practical measure of muscle function, and large observational studies link lower strength with a higher risk of death and cardiovascular disease. A meta-analysis of 42 prospective studies found these associations in both men and women. It did not show that increasing a dynamometer score by itself prevents those outcomes. Study

Comparing your result with men of a similar age can help put it in context. What matters next is whether the result reflects your usual strength, an injury or painful joint, reduced activity, an illness, or another treatable problem. Grip strength is informative precisely because it brings together several influences; it does not identify any one of them on its own.

Average male grip strength by age

The reference values below come from 12 British population studies, combining 60,803 observations from 49,964 participants. They are modeled values at the exact ages shown, not decade-wide diagnostic boundaries. The median is the middle result, and the 25th–75th percentile interval contains the middle half of the reference distribution.

• Age 20: median 40 kg; middle half 35–46 kg.
• Age 30: median 51 kg; middle half 44–58 kg.
• Age 40: median 50 kg; middle half 44–57 kg.
• Age 50: median 48 kg; middle half 41–54 kg.
• Age 60: median 45 kg; middle half 39–51 kg.
• Age 70: median 39 kg; middle half 34–44 kg.
• Age 80: median 32 kg; middle half 27–37 kg.

The analysis used each person’s maximum available grip reading, usually from repeated trials of both hands. It combined several dynamometers and both seated and standing protocols. These are not specifically NHANES values, dominant-hand averages, or the mean of three Jamar trials. Do not compare a three-trial average directly with a maximum-based reference as though they were identical measures.

Being outside the middle half does not automatically mean that something is wrong: half of the reference population falls outside that interval. Height, body size, work, training history, pain, and the measurement procedure all affect interpretation. Record which hand was tested rather than assuming that the nondominant hand must be a fixed percentage weaker.

The EWGSOP2 clinical cutoff for men

The European Working Group on Sarcopenia in Older People, or EWGSOP2, uses grip strength below 27 kg in men as one way to identify low muscle strength. Low strength is a key criterion for probable sarcopenia. Low muscle quantity or quality is then used to confirm the diagnosis; poor physical performance indicates severe sarcopenia. This is more than a generic screening flag, but grip strength alone does not establish confirmed sarcopenia. Consensus

A result above 27 kg does not rule out a substantial decline or another cause of weakness. For example, 28 kg in a 45-year-old man is well below the age-45 median of 49 kg in the British reference data, even though it is above the EWGSOP2 cutoff. Age-related comparisons and clinical thresholds answer different questions.

What can cause below-average grip strength in men?

Lower testosterone

Testosterone contributes to muscle maintenance, and low testosterone can be one factor in reduced strength. A cross-sectional study of 403 men aged 73–94 found associations between testosterone, including its non-SHBG-bound fraction, and muscle strength and body composition. It cannot establish that low testosterone caused a particular man’s weak grip or that treatment will restore it. Study

Testosterone changes with age vary with health, body composition, sampling, and study design. An older meta-analysis emphasized that variation rather than supporting one fixed annual decline for every man. Review

Testing is most useful when other symptoms or signs suggest testosterone deficiency. The Endocrine Society guideline calls for compatible symptoms and consistently low concentrations, usually assessed with morning fasting total testosterone and a repeat measurement. Free testosterone is useful in selected circumstances. Low grip strength alone is not a reason to start testosterone treatment.

Low IGF-1

Insulin-like growth factor 1, or IGF-1, is involved in growth hormone signaling and muscle biology. In a cross-sectional study of 3,276 older patients, IGF-1 was associated with appendicular muscle mass after adjustment for other measured factors. That supports a possible biological connection, not a stand-alone diagnostic test for the cause of weakness. Study

IGF-1 is influenced by age, nutrition, and illness. Its measurement may be useful in an endocrine evaluation, but a low grip reading does not by itself justify growth hormone testing or treatment.

Vitamin D deficiency

Vitamin D has a role in neuromuscular function, and substantial deficiency can accompany muscle weakness. Correcting a documented deficiency is different from expecting supplements to strengthen everyone’s grip. NIH overview

The cited meta-analysis of 54 randomized placebo-controlled trials involving 8,747 people did not find an overall handgrip benefit from vitamin D. Some other performance measures were slightly worse with supplementation, and subgroup analyses of trials with low baseline vitamin D did not establish a benefit. This does not make deficiency irrelevant; it means the trial evidence does not support vitamin D as a general grip-strength booster. Review

Anemia and iron deficiency

Iron supports oxygen transport and other functions needed for physical performance. Anemia can contribute to fatigue and reduced exercise capacity, while iron deficiency may be present before hemoglobin falls. Neither condition can be diagnosed from grip strength alone.

Ferritin helps assess iron stores, but inflammation can raise it and complicate interpretation. A clinician may consider a blood count, ferritin, and other iron studies when the history suggests deficiency or blood loss. A single low grip reading is not a reason to take iron without checking the cause. NIH iron guidance

Insulin resistance and metabolic health

Skeletal muscle is important for glucose disposal. Insulin resistance, fat within muscle, inflammation, inactivity, and muscle loss can interact. A review describes these biological pathways and the association between metabolic syndrome and sarcopenia; it does not establish a uniform rate of muscle loss for all men with metabolic syndrome. Review

Glucose or A1c testing may be relevant to someone’s metabolic risk. Fasting insulin is not a complete measure of insulin sensitivity, and clinical testing for insulin resistance itself is not generally routine. A low grip score does not establish insulin resistance. NIDDK guidance

Chronic inflammation

Inflammatory pathways can contribute to muscle breakdown. A systematic review found small associations between higher circulating inflammatory markers and lower muscle strength and mass. For handgrip strength, the pooled correlation with CRP was about −0.10. Review

These associations are useful for research but do not show that inflammation is the cause of an individual’s weakness. CRP is nonspecific; a raised result needs to be interpreted alongside symptoms, illness, and other findings.

How to get a reliable grip-strength measurement

Consistency matters more than chasing a single high score. Use a calibrated dynamometer, follow its validated protocol, and record the device, handle setting, hand tested, posture, number of attempts, and whether the reported value is the best effort or the mean.

A common clinical protocol uses a seated position with the elbow bent to 90 degrees and repeated efforts with each hand. Jamar devices are widely used, but other validated devices also exist. The British norms above used the maximum reading rather than a universal three-trial average. Follow the protocol behind the reference you plan to use, allowing appropriate rest between attempts.

Pain, a recent hand injury, hard training, and fatigue can lower a reading. A substantial change deserves a repeat under comparable conditions and, if it persists or affects daily tasks, a clinical assessment. Broader function, such as standing up from a chair and walking, can provide information that squeezing a handle misses.

What helps preserve grip strength over time?

Progressive resistance training can improve strength, and work for the forearms and hands can be part of a program that trains the whole body. Adequate food and protein intake, recovery, and treatment of an identified illness or deficiency also matter.

Protein needs depend on age, training, overall energy intake, and health. The cited review of healthy older adults describes genuine disagreement about how requirements should be measured; it does not establish a universal target of 1.6–2.2 g/kg/day for every man. Review

A separate meta-analysis of resistance-training trials in healthy adults found no further average gain in fat-free mass beyond a total protein intake of about 1.6 g/kg/day. That figure concerns training-related muscle gain, not a minimum requirement for normal grip strength. More protein is not automatically better, and medical conditions may change the appropriate intake. Training meta-analysis

Which blood tests can complement a grip-strength assessment?

There is no standard blood panel that explains every low grip result. History, examination, repeat measurement, and broader functional testing come first. The following tests answer different questions and should be chosen for a reason:

• IGF-1: may contribute to a specific endocrine assessment; it is not a direct measurement of muscle mass.
• 25-hydroxyvitamin D: assesses vitamin D status when deficiency is clinically suspected or testing is otherwise indicated; it does not measure muscle receptor activity.
• Ferritin and a blood count: help investigate iron deficiency or anemia when symptoms or risk factors fit. Ferritin is affected by inflammation.
• Fasting insulin: is not a routine first-line test for an isolated low grip reading and does not, by itself, fully describe insulin sensitivity.
• CRP or hs-CRP: can reflect inflammation in the right setting, but cannot establish why muscle strength is low.
• A1c or glucose: may help assess diabetes risk or glucose regulation when indicated; these do not directly measure muscle health.

Testosterone testing may be appropriate when additional signs suggest deficiency. The purpose is to find an actionable explanation, not to order every marker associated with muscle function in population studies.

More questions about interpreting your result

What grip strength is usual in middle adulthood?

In the British data, the median was 50 kg at age 40 and 49 kg at age 45. The middle half at age 45 ranged from 42 to 56 kg. These are reference values for maximum grip readings, not a rule that every man below 42 kg has a medical problem. A repeated decline, difficulty with daily tasks, or other symptoms makes the result more clinically relevant.

When does grip strength peak?

The British study found a peak median of about 51 kg between ages 29 and 39, followed by relative maintenance into midlife and later decline. Cross-sectional age curves cannot tell you the annual rate at which a particular person will lose strength.

Does grip strength tell us about whole-body strength?

It is a useful indicator of general muscle function, but it is not interchangeable with leg strength, muscle mass, or walking ability. Hand pain or injury can make it particularly misleading as a whole-body measure. More comprehensive tests may be needed.

Does testosterone play a role?

Yes. It contributes to muscle biology, and observational studies link testosterone measures with strength in older men. Bioavailable testosterone commonly refers to the free and albumin-bound fractions, rather than the fraction bound to sex hormone-binding globulin. An association does not mean that every weak grip is a hormone deficiency.

Which blood tests are a reasonable starting point?

That depends on the symptoms and examination. For example, fatigue or suspected blood loss may lead to a blood count and iron assessment, while signs of diabetes may lead to glucose testing. IGF-1, fasting insulin, hs-CRP, and testosterone are not a default package for everyone with below-average grip strength.

This article provides information rather than a diagnosis. Persistent weakness is best considered alongside the rest of your health and everyday function.

Frequently asked questions

What is average grip strength for a man in his 30s?

In the British reference study, the median was 51 kg at both ages 30 and 35. The middle half ranged from 44–58 kg at 30 and 45–58 kg at 35. These values describe maximum readings from the study protocols, not a dominant-hand average across three attempts. Body size, training, pain, and technique all affect an individual result.

How quickly does men’s grip strength decline with age?

There is no single annual percentage that applies to all men from age 40 onward. In the reference data, medians were 50 kg at 40, 48 kg at 50, 45 kg at 60, 39 kg at 70, and 32 kg at 80. Those are comparisons between age groups, not measured yearly losses in one person. Training, health, nutrition, and periods of inactivity can change an individual’s course.

What is the EWGSOP2 grip-strength cutoff for men, and what does it mean?

Below 27 kg indicates low strength within the EWGSOP2 framework and supports probable sarcopenia. Low muscle quantity or quality is needed to confirm sarcopenia, and poor physical performance indicates greater severity. A result above the cutoff does not rule out a clinically important change from someone’s previous strength.

Can low testosterone contribute to below-average grip strength?

It can contribute to muscle weakness, but a grip test cannot diagnose it. Testosterone evaluation is more useful when compatible symptoms or signs are present. Diagnosis requires consistently low levels, ordinarily confirmed with a repeat morning measurement, rather than one isolated result or an age comparison.

Which blood tests are most useful when a man’s grip is low for his age?

There is no universal first-line panel. The choice follows the history and examination: for example, a blood count and iron studies for suspected anemia, or glucose testing for relevant metabolic symptoms or risk. A below-average score alone does not justify testing every hormone, nutrient, and inflammatory marker.

How does insulin resistance affect grip strength and muscle mass?

Muscle handles a large share of insulin-mediated glucose uptake, while insulin resistance, inactivity, fat accumulation, and inflammation can contribute to impaired muscle health. The relationship can run in both directions. A low grip reading does not reveal how much of that process is present, and fasting insulin does not provide a complete diagnosis by itself.

Can vitamin D deficiency contribute to low grip strength in men?

Marked deficiency can be associated with weakness and should be addressed when identified. But a large randomized-trial meta-analysis did not show that vitamin D supplementation generally improves handgrip strength, even in its low-vitamin-D subgroup analyses. Treating deficiency and promising a grip-strength boost are different claims.

What is the most accurate way to measure grip strength at home or in a clinic?

Use a calibrated device and a repeatable protocol that matches the reference values. Record the hand, posture, handle setting, attempts, and whether you use the maximum or average. A seated position with the elbow at 90 degrees is common, but it is not the only validated protocol. Pain, recent training, and fatigue should be recorded rather than ignored.

Sources and evidence

Wu Y, Wang W, Liu T, Zhang D (2017). Association of Grip Strength With Risk of All-Cause Mortality, Cardiovascular Diseases, and Cancer in Community-Dwelling Populations: A Meta-analysis of Prospective Cohort Studies. Journal of the American Medical Directors Association, 18(6), 551.e17-551.e35. https://doi.org/10.1016/j.jamda.2017.03.011 Publication

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing, 48(1), 16-31. https://doi.org/10.1093/ageing/afy169 Publication

Gray A, Berlin JA, McKinlay JB, Longcope C (1991). An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. Journal of clinical epidemiology, 44(7), 671-84. https://doi.org/10.1016/0895-4356(91)90028-8 Publication

van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW (2000). Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. The Journal of clinical endocrinology and metabolism, 85(9), 3276-82. https://doi.org/10.1210/jcem.85.9.6825 Publication

Bian A, Ma Y, Zhou X, Guo Y, Wang W, Zhang Y, Wang X (2020). Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC musculoskeletal disorders, 21(1), 214. https://doi.org/10.1186/s12891-020-03236-y Publication

Bislev LS, Grove-Laugesen D, Rejnmark L (2021). Vitamin D and Muscle Health: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 36(9), 1651-1660. https://doi.org/10.1002/jbmr.4412 Publication

Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K (2021). Metabolic Syndrome and Sarcopenia. Nutrients, 13(10). https://doi.org/10.3390/nu13103519 Publication

Tuttle CSL, Thang LAN, Maier AB (2020). Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis. Ageing research reviews, 64, 101185. https://doi.org/10.1016/j.arr.2020.101185 Publication

Nishimura Y, Højfeldt G, Breen L, Tetens I, Holm L (2023). Dietary protein requirements and recommendations for healthy older adults: a critical narrative review of the scientific evidence. Nutrition research reviews, 36(1), 69-85. https://doi.org/10.1017/S0954422421000329 Publication

Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, Der G, Gale CR, Inskip HM, Jagger C, Kirkwood TB, Lawlor DA, Robinson SM, Starr JM, Steptoe A, Tilling K, Kuh D, Cooper C, Sayer AA. Grip strength across the life course: normative data from twelve British studies. PloS one. 2014. https://doi.org/10.1371/journal.pone.0113637 PubMed

Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018. https://doi.org/10.1210/jc.2018-00229 PubMed

Morton RW, Murphy KT, McKellar SR, Schoenfeld BJ, Henselmans M, Helms E, Aragon AA, Devries MC, Banfield L, Krieger JW, Phillips SM. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British journal of sports medicine. 2018. https://doi.org/10.1136/bjsports-2017-097608 PubMed

National Institutes of Health Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

National Institutes of Health Office of Dietary Supplements. Iron: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/

National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance